Mundla Maha Vishnu

Mundla Maha Vishnu

Active Director Designated Partner DIN 02470664
DIN 02470664 First appointment Feb 2006 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 16 active board seats
Past companies 2 historical roles
Total affiliations 18 Since Feb 2006
Shareholding value Locked Premium profile
Directorship timeline
First appointment 17 Feb 2006
Active appointments 18
Total timeline records 18

Appointment history

Since 2006
Vision Drugs Private Limited Additional Director · 2025 - 2026
Current
Emmennar Pharma Containers Private Limited Additional Director · 2025 - 2026
Current
Ceph Lifesciences Private Limited Additional Director · 2025 - 2026
Current
Covalent Laboratories Private Limited Director · 2024 - 2026
Current
Virchow Biotech Private Limited Director · 2024 - 2026
Current
Sv Real Holdings Private Limited Director · 2022 - 2026
Current
Aarna & Akshaj Industries Private Limited Managing Director · 2021 - 2026
Current
Alithia Pharmaceuticals Private Limited Director · 2021 - 2026
Current
Azico Pharmaceuticals Private Limited Director · 2021 - 2026
Current
Synac Pharmaceuticals Private Limited Director · 2021 - 2026
Current
Pista Motor Raceway Llp Designated Partner · 2020 - 2026
Current
Virchow Laboratories Limited Director · 2018 - 2026
Current
Siri Drugs India Private Limited Director · 2015 - 2026
Current
Virchow Petrochemical Private Limited Director · 2014 - 2026
Current
Emnar Pharma Private Limited Director · 2011 - 2026
Current
Emmennar Chem Private Limited Director · 2011 - 2026
Current
Andhra Organics Limited Whole-Time Director · 2011 - 2026
Current
Saraca Laboratories Limited Director · 2006 - 2026
Current

Interactive timeline

Hover bars for tenure details
Loading chart...
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available